Updated clinical safety experience with fluvastatin
Author:
- 1 May 1994
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 73 (14) , D18-D24
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisJAMA, 1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJACC, 1986
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJAMA, 1986
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study.Circulation, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975